ZAI LAB (09688) closes private placement of a total of 11.34 million American Depositary Shares

ZAI LAB (09688) announced that on October 27, 2026 (Eastern Time), it closed a private placement of a total of 11.34 million American Depositary Shares. Leerink Partners LLC acted as the sole placement agent for the private placement. The Company intends to use the net proceeds from the private placement primarily to support the continued global development of its Delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC) targeting Zocilurtatug Pelitecan (zoci).